Several studies reveal that the cargoes released from the tumor-derived EVs affect the cell’s metabolism by altering the pathways to ones that can easily support the tumor microenvironment during different hallmarks of cancer; for example, the activation of the MAP/ERK pathway leads to the initiation of the tumor. Here, EPHB2 is linked to cancer.